Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Inozyme Pharma Inc (INZY)

Inozyme Pharma Inc (INZY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Inozyme Pharma to Present at Upcoming Investor Conferences GlobeNewswire - Mon Nov 11, 7:30AM CST

INZY : 2.81 (-2.43%)
Inozyme Pharma Reports Third Quarter 2024 Financial Results and Provides Business Highlights GlobeNewswire - Tue Nov 5, 7:30AM CST

INZY : 2.81 (-2.43%)
Inozyme Pharma Announces Positive Interim Data from Phase 1 SEAPORT 1 Trial of INZ-701 GlobeNewswire - Thu Oct 24, 12:15PM CDT

INZY : 2.81 (-2.43%)
Inozyme Pharma Announces Presentation of Interim Data from Phase 1 SEAPORT 1 Trial at the Upcoming American Society of Nephrology (ASN) Kidney Week 2024 GlobeNewswire - Thu Oct 17, 7:30AM CDT

INZY : 2.81 (-2.43%)
Inozyme Pharma Announces Appointment of Biopharmaceutical Commercial Leader Erik Harris to its Board of Directors GlobeNewswire - Mon Oct 7, 7:30AM CDT

INZY : 2.81 (-2.43%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inozyme Pharma, Inc. - INZY PR Newswire - Fri Aug 18, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Inozyme Pharma, Inc. ("Inozyme" or the "Company") (NASDAQ: INZY). Such...

INZY : 2.81 (-2.43%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inozyme Pharma, Inc. - INZY PR Newswire - Thu Aug 10, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Inozyme Pharma, Inc. ("Inozyme" or the "Company") (NASDAQ: INZY). Such...

INZY : 2.81 (-2.43%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inozyme Pharma, Inc. - INZY PR Newswire - Fri Aug 4, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Inozyme Pharma, Inc. ("Inozyme" or the "Company") (NASDAQ: INZY). Such...

INZY : 2.81 (-2.43%)
Jon Soderstrom Joins Wilson Sonsini as Chief Licensing Advisor Business Wire - Mon Nov 28, 2022

Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, announced today that Jon Soderstrom is joining the firm as its chief...

ACHN : 0.7912 (-21.66%)
ARVN : 21.64 (-6.68%)
NXTC : 1.3100 (+1.55%)
BHVN : 46.30 (+1.96%)
INZY : 2.81 (-2.43%)
Inozyme Pharma Secures Flexible Debt Facility for up to $70 Million with K2 HealthVentures Globe Newswire - Tue Jul 26, 2022

BOSTON, July 26, 2022 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel...

INZY : 2.81 (-2.43%)

Barchart Exclusives

Has the Global Wheat Market Changed? Barchart - Tue Nov 19, 6:49PM CST
The spotlight has turned to global wheat markets this week as the situation in the Black Sea region of the world intensifies. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot